Psychiatry

Top Story

Novel psychotropic agent improves symptoms in schizophrenia

Novel psychotropic agent improves symptoms in schizophrenia
May 24, 2019
Meeting NewsVideo

Psychiatrists: Meet veterans ‘where they are’

May 24, 2019
SAN FRANCISCO — In a video interview, Elspeth “Cam” Ritchie, MD, MPH, a psychiatrist in Washington, D.C., and member of the Healio Psychiatry Peer…
Meeting News

Vraylar appears to improve cognitive symptoms in schizophrenia

May 23, 2019
SAN FRANCISCO — Post hoc analysis data presented at the APA annual meeting demonstrated that Vraylar, made by Allergan, may offer benefits for cognition symptoms…
Meeting News

Potentially FDA-approved medications face significant scrutiny on their printed materials

May 23, 2019
WASHINGTON — The FDA’s Office of Prescription Drug Promotion uses many methods to assess the validity of a potential medication’s print advertising…
More Headlines »
CME Article

Continuation Therapies After Successful Treatment with Electroconvulsive Therapy in Major Depressive Disorder

Psychiatric Annals, April 2019, Volume 49 Issue 4
Although the use of electroconvulsive therapy (ECT) predates the use of any other biologic treatment for major…
More »
CME

Curbside Consults in Bipolar Disorder: Selecting and Implementing the Best Medication Regimen for your Patients

This activity is supported by educational grants from Otsuka America Pharmaceutical, Inc. and Lundbeck; and Sunovion Pharmaceuticals Inc.

Bipolar disorder comprises a spectrum of diseases, characterized by recurrent periods of mania, hypomania, or episodes…
More »
Resource Centers
APA Annual Meeting

APA Annual Meeting

Video
Meeting News

VIDEO: Smartphone apps for serious mental illness

May 20, 2019
More »
Healio Jobs